Weis Shirley A 4

What Happened Shirley A. Weis, a director of Pediatrix Medical Group, sold 36,028 shares in an open-market transaction on May 13, 2026, for a weighted average price of $23.75, generating proceeds of approximately $855,665. This was a sale (not a purchase or option exercise) and therefore is generally considered a liquidity/portfolio transaction rather than a direct bullish signal.

Key Details

• Transaction date: May 13, 2026; filing date: May 14, 2026 (timely).
• Shares sold: 36,028; weighted average sale price: $23.75; total proceeds: $855,665.
• Price range: sales executed at prices between $23.55 and $23.85 (weighted average per footnote).
• Ownership after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 notes the weighted-average price and offers to provide per-price breakdown on request; F2 states the reporting person and her husband are trustees of the trust that holds the securities and immediate-family members are beneficiaries.

Context This Form 4 reports a sale by a company director through a trust. Sales by insiders can be routine (e.g., trust or estate management, diversification or tax planning) and do not by themselves indicate management’s view of the company’s prospects. The filing shows the trade was executed across multiple transactions at slightly different prices; no option exercises, gifts, or 10b5-1 plan disclosures were reported in the provided excerpt.